Basic biochemical and pharmacological aspects of antiviral agents.
D000212:Acyclovir / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000547:Amantadine / Q000494:pharmacology* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000096:biosynthesis; D006564:Herpesviridae / Q000187:drug effects; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology* / Q000627:therapeutic use; D009980:Influenza A virus / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D007251:Influenza, Human / Q000188:drug therapy; D007635:Keratitis, Dendritic / Q000188:drug therapy; D012367:RNA, Viral / Q000096:biosynthesis; D012435:S-Adenosylhomocysteine / Q000378:metabolism; D013937:Thymidine Kinase / Q000378:metabolism; D014271:Trifluridine / Q000494:pharmacology / Q000627:therapeutic use; D014740:Vidarabine / Q000494:pharmacology* / Q000627:therapeutic use; D014764:Viral Proteins / Q000096:biosynthesis; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D004279:DNA, Viral; D012367:RNA, Viral; D014764:Viral Proteins; D012435:S-Adenosylhomocysteine; D000547:Amantadine; D013937:Thymidine Kinase; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D000212:Acyclovir